Pharmacokinetics of the antifungal drug micafungin in mice, rats and dogs, and its in vitro protein binding and distribution to blood cells

Japanese Journal of Chemotherapy

Volumn 50, Issue , 2002, Pages 74-79

  Yamato, Yasuhiro ^a   Kaneko, Hayato ^a   Hashimoto, Tomoko ^a   Katashima, Masataka ^a   Ishibashi, Koji ^a   Kawamura, Akio ^a   Terakawa, Masato ^a   Kagayama, Akira ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN B; MICAFUNGIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL; BOLUS INJECTION; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOG; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG STRUCTURE; FEMALE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; RAT; STEADY STATE;

EID: 0036924676     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: 10.11250/chemotherapy1995.50.Supplement1_74     Document Type: Article

References (1)

1. Hajidu R, Thompson R, Sundelof J G, et. al. : Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743, 872). Antimicrob Agents Chemother 41 : 2339~2344, 1997